V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006428 | 310007446 | 1.69 | 67.9 | Neo-adjuvant (N) | 2014-10-10 | 2014-12-18 | CHOP | N | null | 310006819 | CHOP |
| 310006429 | 310003594 | 1.67 | 77 | Disease modification (D) | 2015-07-17 | 2015-11-08 | CHOP - 14 days | 2 | N | 310006819 | CHOP |
| 310006430 | 310003595 | 1.69 | null | Palliative (P) | 2016-10-31 | 2016-11-03 | SMILE | 02 | null | 310006823 | TRIAL |
| 310006431 | 310003599 | 1.67 | 44.4 | Palliative (P) | 2013-04-04 | 2013-04-19 | GemCarbo Days 1+8 | N | N | 310006829 | GEMCARBO |
| 310006432 | 310009469 | 1.55 | 67.6 | Adjuvant (A) | 2015-08-09 | 2015-08-10 | Trial Unspecified | 2 | N | 310006829 | TRIAL |
| 310006433 | 310003600 | 1.64 | 73 | Palliative (P) | 2017-02-09 | 2017-02-17 | Liposomal Doxorubicin 50mg/m2 | N | null | 310006847 | LIPOSOMAL DOXORUBICIN |
| 310006434 | 310003600 | 1.76 | null | Palliative (P) | 2017-05-05 | 2018-01-26 | GEMCARBO | 2 | Y | 310006847 | GEMCARBO |
| 310006435 | 310003600 | 1.8 | 72 | Adjuvant (A) | 2014-05-23 | 2014-05-23 | CHOP - 21 days | 2 | N | 310006847 | CHOP |
| 310006436 | 310003602 | 1.67 | 84.4 | Palliative (P) | 2014-08-22 | 2014-09-05 | Liposomal Doxorubicin (Caelyx) | 02 | null | 310006858 | LIPOSOMAL DOXORUBICIN |
| 310006437 | 310003602 | 1.54 | 56 | Neo-adjuvant (N) | 2014-06-27 | 2014-07-01 | CHOP - 21 days | 02 | N | 310006858 | CHOP |
| 310006438 | 310003602 | 1.6 | 55 | Palliative (P) | 2014-01-24 | 2014-02-01 | Trial Unspecified | N | null | 310006858 | TRIAL |
| 310006439 | 310003603 | 1.65 | 68.85 | Curative (C) | 2016-06-30 | 2017-01-12 | Bevacizumab 7.5mg/kg | N | N | 310006866 | BEVACIZUMAB |
| 310006440 | 310003604 | 1.68 | 74.7 | Palliative (P) | 2017-12-28 | 2017-12-31 | Bevacizumab | N | N | 310006869 | BEVACIZUMAB |
| 310006441 | 310003605 | 1.73 | 65 | Neo-adjuvant (N) | 2015-09-24 | 2016-01-16 | Bevacizumab 7.5mg/kg | N | null | 310006872 | BEVACIZUMAB |
| 310006442 | 310003607 | null | 88.8 | Curative (C) | 2018-04-13 | 2018-05-13 | Trial Unspecified | 02 | null | 310006873 | TRIAL |
| 310006443 | 310003607 | 1.8 | 69.9 | Adjuvant (A) | 2014-04-10 | 2014-04-14 | Bevacizumab | N | N | 310006873 | BEVACIZUMAB |
| 310006446 | 310003608 | 1.79 | 95 | Palliative (P) | 2017-05-21 | 2017-05-31 | GEMCARBO | N | N | 310006895 | GEMCARBO |
| 310006447 | 310010549 | null | 85.3 | Palliative (P) | 2016-10-29 | 2016-11-20 | Liposomal Doxorubicin (Caelyx) | 02 | null | 310006900 | LIPOSOMAL DOXORUBICIN |
| 310006448 | 310003610 | 1.82 | 69.3 | Adjuvant (A) | 2014-08-08 | 2014-08-15 | Trial Unspecified | 02 | N | 310006907 | TRIAL |
| 310006449 | 310003614 | 1.7 | 123.1 | Palliative (P) | null | 2015-04-25 | Bevacizumab | N | N | 310006908 | BEVACIZUMAB |
| 310006450 | 310003616 | 1.58 | 66.4 | Palliative (P) | 2015-11-08 | 2015-12-06 | GemCarbo Days 1+8 | N | N | 310006908 | GEMCARBO |
| 310006451 | 310003616 | 1.59 | 100 | Palliative (P) | 2016-05-23 | 2016-05-29 | CARBOPLATIN + GEMCITABINE | N | N | 310006908 | GEMCARBO |
| 310006452 | 310007457 | 1.73 | 91.2 | Disease modification (D) | 2013-10-23 | 2013-10-23 | CHOP - 21 days | 02 | N | 310006914 | CHOP |
| 310006453 | 310003618 | 1.55 | 77.8 | Curative (C) | 2015-01-14 | 2015-01-15 | Bevacizumab 7.5mg/kg | null | N | 310006915 | BEVACIZUMAB |
| 310006454 | 310003621 | 1.96 | 64.9 | Palliative (P) | 2016-07-28 | 2016-07-29 | Bevacizumab 7.5mg/kg | N | null | 310006928 | BEVACIZUMAB |
| 310006455 | 310003624 | 1.8 | 75.2 | Palliative (P) | 2017-07-16 | 2017-07-16 | Trial Unspecified | Y | N | 310006931 | TRIAL |
| 310006456 | 310003625 | null | 89.5 | Curative (C) | 2015-06-30 | 2015-07-22 | Liposomal Doxorubicin 50mg/m2 | N | N | 310006933 | LIPOSOMAL DOXORUBICIN |
| 310006457 | 310003626 | 1.6 | null | Palliative (P) | 2015-07-30 | 2015-08-05 | Trial Unspecified | 01 | Y | 310006936 | TRIAL |
| 310006461 | 310003631 | 1.6 | 67.9 | Neo-adjuvant (N) | null | 2018-05-13 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310006949 | LIPOSOMAL DOXORUBICIN |
| 310006462 | 310003631 | null | 45.4 | Neo-adjuvant (N) | 2015-11-27 | 2016-06-08 | GemCarbo Days 1+8 | 02 | null | 310006949 | GEMCARBO |
| 310006463 | 310003632 | null | 127.2 | Palliative (P) | 2018-04-20 | 2018-04-21 | Liposomal Doxorubicin (Caelyx) | N | N | 310006958 | LIPOSOMAL DOXORUBICIN |
| 310006464 | 310003632 | null | 71.2 | Palliative (P) | 2017-04-01 | 2017-04-29 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310006958 | LIPOSOMAL DOXORUBICIN |
| 310006465 | 310003633 | 1.63 | 69 | Adjuvant (A) | null | 2015-03-24 | CHOP - 21 days | N | null | 310006963 | CHOP |
| 310006466 | 310007464 | null | null | Palliative (P) | 2015-07-05 | 2015-09-20 | Bevacizumab | 02 | Y | 310006963 | BEVACIZUMAB |
| 310006467 | 310007464 | null | 32.4 | Palliative (P) | 2015-09-04 | 2015-09-12 | Trial Unspecified | N | N | 310006963 | TRIAL |
| 310006468 | 310003634 | null | 93 | Palliative (P) | 2013-03-26 | 2014-01-25 | Bevacizumab 15mg/kg | N | N | 310006978 | BEVACIZUMAB |
| 310006469 | 310003636 | null | null | Not known (9) | 2013-06-14 | 2013-11-29 | Bevacizumab 7.5mg/kg | 02 | N | 310006979 | BEVACIZUMAB |
| 310006470 | 310003637 | 1.8 | null | Neo-adjuvant (N) | 2016-06-02 | 2016-06-08 | Bevacizumab 7.5mg/kg | N | N | 310006979 | BEVACIZUMAB |
| 310006471 | 310003639 | 1.48 | null | Palliative (P) | 2014-03-04 | 2014-03-09 | GemCarbo Days 1+8 | N | N | 310006982 | GEMCARBO |
| 310006472 | 310007466 | 1.55 | 69.5 | Not known (9) | 2016-01-17 | 2016-04-29 | Bevacizumab 15mg/kg | N | N | 310006984 | BEVACIZUMAB |
| 310006473 | 310003641 | 1.75 | 75.2 | Palliative (P) | 2015-03-29 | 2015-10-07 | GemCarbo Days 1+8 | 02 | N | 310006986 | GEMCARBO |
| 310006474 | 310009479 | null | 79 | Neo-adjuvant (N) | 2013-09-18 | 2013-10-08 | Bevacizumab 15mg/kg | null | N | 310007004 | BEVACIZUMAB |
| 310006475 | 310003644 | 1.62 | 55.7 | Curative (C) | 2017-07-18 | 2017-08-09 | Trial Unspecified | 01 | N | 310007023 | TRIAL |
| 310006476 | 310007470 | 1.68 | 74.7 | Disease modification (D) | 2016-08-16 | 2016-08-28 | CHOP - 21 days | N | N | 310007031 | CHOP |
| 310006477 | 310003646 | 1.65 | 92 | Neo-adjuvant (N) | 2016-11-09 | 2016-11-15 | Bevacizumab 7.5mg/kg | N | N | 310007031 | BEVACIZUMAB |
| 310006478 | 310010553 | 1.67 | 72.6 | Palliative (P) | 2015-07-15 | 2015-07-16 | Liposomal Doxorubicin (Caelyx) | N | N | 310007034 | LIPOSOMAL DOXORUBICIN |
| 310006479 | 310003647 | 1.7 | 72.5 | Curative (C) | 2015-01-03 | 2015-01-03 | CHOP - 21 days | N | N | 310007041 | CHOP |
| 310006480 | 310003649 | 1.84 | null | Neo-adjuvant (N) | 2013-05-20 | 2013-06-27 | CHOP - 21 days | N | N | 310007041 | CHOP |
| 310006481 | 310003650 | null | null | Palliative (P) | 2016-01-05 | 2016-01-06 | Trial Unspecified | N | N | 310007044 | TRIAL |
| 310006482 | 310003651 | 1.63 | 52.8 | Palliative (P) | null | 2016-01-05 | Trial Unspecified | 1 | N | 310007048 | TRIAL |